MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Next-generation sequencing analysis of circulating microRNAs in multiple system atrophy

    MC. Kuo, SP. Lin, RM. Wu (Taipei, Taiwan)

    Objective: The discriminatory peripheral circulating small non-coding RNAs (sncRNAs) using next-generation sequencing (NGS) between patients of multiple system atrophy (MSA), Parkinson's disease (PD), and healthy controls…
  • 2023 International Congress

    Post-Covid parkinsonism: a systematic review of clinical presentations

    P. Polverino, S. Lalli, M. Lo Giudice, A. Albanese (Rozzano, Italy)

    Objective: We performed a critical appraisal of the COVID-19-related parkinsonism cases reported in the literature so far, providing a phenomenological and diagnostic framework based on…
  • 2023 International Congress

    The pivotal difference in gut microbiota between multiple system atrophy and Parkinson’s disease

    SY. Cheng, MC. Kuo, YF. Tseng (Taipei, Taiwan)

    Objective: The knowledge gap between microbiome dysbiosis and pathogenesis of multiple system atrophy (MSA) remains. Background: Mounting evidence has found significant alterations in the gut…
  • 2023 International Congress

    Preliminary Report on Neuromelanin-Sensitive MRI Signal change after Allogeneic Bone marrow-derived Mesenchymal Stem Cells therapy: Phase IIa double-blind, randomized controlled trial

    J. Suescun, M. Schiess, E. Rodarte, C. Adams, T. Ellmore (Houston, USA)

    Objective: To select the most effective number of repeat doses of mesenchymal stem cells (MSC) delivered intravenously to slow the progression of Parkinson’s disease (PD).…
  • 2023 International Congress

    Motor phenotype and disease burden among Parkinson’s disease patients of Addis Ababa, Ethiopia.

    B. Getahun, H. Demissie, H. Nuri, S. Gugssa (Dire Dawa, Ethiopia)

    Objective: This study aims to characterize the motor phenotype of Parkinson’s disease (PD), compare disease severity and to determine quality of life among the different…
  • 2023 International Congress

    Crushing valbenazine capsule contents for potential addition to soft foods or administration via G tube

    M. Hebert, A. Mar, R. Moore, A. Bristow, S. Siegert (San Diego, USA)

    Objective: To evaluate the suitability of mixing crushed contents from valbenazine capsules with soft foods/liquids or adding them to water for delivery through a gastrostomy…
  • 2023 International Congress

    Depression profile in Mexican patients with Parkinson Disease: a cross-sectional study

    P. Reyes-Pérez, A. Medina-Rivera, A. Ruiz-Contreras, S. Alcauter-Solorzano, M. Rentería, A. Lazaro-Figueroa, Y. Matuk-Pérez, N. Gandarilla-Martínez, K. Salinas-Barboza, I. Estrada-Bellmann (Queretaro, Mexico)

    Objective: The present study aimed to provide a better understanding of depression manifestations in Mexican PD patients within the Mexican Parkinson’s Disease Research Network (MexPD),…
  • 2023 International Congress

    Cortical Control of Gait and Balance During Single and Dual Tasks in Huntington’s Disease: an fNIRS study

    J. O'Keefe, N. Purcell, S. Stuart, R. Vitorio, B. Ouyang, D. Hall (Chicago, USA)

    Objective: To examine the cortical control of gait and balance in HD under single-task (ST) and dual-task (DT) conditions compared to healthy controls using portable…
  • 2023 International Congress

    Investigation of superficial brain stimulation (SBS) in Parkinsonian rats as a non-invasive alternative treatment for patients with movement disorders

    G. Weistroffer, J. Blagg, M. Tashli, R. Hadimani, D. Kumbhare, M. Baron (Richmond, USA)

    Objective: To investigate repetitive transcranial magnetic stimulation (rTMS) in parkinsonian rats as a non-invasive, malleable superficial brain stimulation (SBS) alternative to DBS. Background: DBS is…
  • 2023 International Congress

    The effect of subthalamic therapeutic deep brain stimulation on pallidal and cortical activity in Parkinson’s disease

    F. Sarmento, J. Hernandez, T. de Araujo, J. Wong, D. Wang, P. Starr, C. de Hemptinne (Gainesville, USA)

    Objective: To evaluate the effect of subthalamic (STN) deep brain stimulation (DBS) on the globus pallidus (GP) and motor cortex Background: Progressive neuronal loss in…
  • « Previous Page
  • 1
  • …
  • 62
  • 63
  • 64
  • 65
  • 66
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Screening and Treatment of Depression in Parkinson’s Disease within Movement Disorders Centers: A Quality Improvement Initiative
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley